Around the world, cancer rates show no sign of slowing down. In fact, they are set to rise more than 70% by 2050.
Every cancer type presents clinicians with diverse challenges. Understanding their nature is crucial.
At EORTC, we take the knowledge from the labs directly to the patient. We help find the most appropriate treatment so that no one is left behind.
For over 60 years, EORTC has been Europe’s leading organisation in improving cancer outcomes through independent clinical trials across cancer types including rare cancers.
Your kindness helps support independent clinical cancer research-advancing treatments for patients across all cancer types.
Thank you for giving hope and supporting the future of cancer therapy.
